Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33159326" target="_blank" >RIV/61989592:15110/16:33159326 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy

Popis výsledku v původním jazyce

This procedure is designed to minimize the risk of bleeding and thromboembolic complications in periprocedurálním period endoscopic procedure. For this reason, it is appropriate to divide patients into groups with low, medium and high risk of thromboembolism (TE) and endoscopic procedures into groups with low and high risk of bleeding. Generally speaking, with increase of risk which has to be the lowest limit or shortest discontinuation of anticoagulant therapy. On the other hand, with a growing risk of bleeding because power is necessary to extend the period during which anticoagulant therapy is discontinued. An important parameter is also the time of thromboembolic episodes until the planned performance. Patients with a history of venous thromboembolism elective surgery should not be performed in the first three months after the attack of TEN. In patients with thromboembolic complications of atrial fibrillation (AF) is the most risky first month of the documentation TE complications and elective surgery should be postponed to as late as possible dates. The procedure shows recommendations regarding the withdrawal and re-deployment of anticoagulant and antithrombotic therapy in patients progressing bronchoscopic examination. Below are possible laboratory methods for monitoring the effectiveness of anticoagulant and antiplatelet therapy on coagulation system and possible methods of therapy eventual periprocedurálního bleeding due to anticoagulation or antiplatelet therapy.

Název v anglickém jazyce

Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy

Popis výsledku anglicky

This procedure is designed to minimize the risk of bleeding and thromboembolic complications in periprocedurálním period endoscopic procedure. For this reason, it is appropriate to divide patients into groups with low, medium and high risk of thromboembolism (TE) and endoscopic procedures into groups with low and high risk of bleeding. Generally speaking, with increase of risk which has to be the lowest limit or shortest discontinuation of anticoagulant therapy. On the other hand, with a growing risk of bleeding because power is necessary to extend the period during which anticoagulant therapy is discontinued. An important parameter is also the time of thromboembolic episodes until the planned performance. Patients with a history of venous thromboembolism elective surgery should not be performed in the first three months after the attack of TEN. In patients with thromboembolic complications of atrial fibrillation (AF) is the most risky first month of the documentation TE complications and elective surgery should be postponed to as late as possible dates. The procedure shows recommendations regarding the withdrawal and re-deployment of anticoagulant and antithrombotic therapy in patients progressing bronchoscopic examination. Below are possible laboratory methods for monitoring the effectiveness of anticoagulant and antiplatelet therapy on coagulation system and possible methods of therapy eventual periprocedurálního bleeding due to anticoagulation or antiplatelet therapy.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FC - Pneumologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

58

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

6

Strana od-do

175-180

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—